According to a study published in Nature Communications, researchers at the National Institutes of Health (NIH) created an ...

Prominent vaccine skeptic RFK, Jr., is a proven menace to public health. But with a bird flu outbreak looming, he is poised ...

Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

Shares of Aclaris Therapeutics ACRS rallied 53.2% on Monday and gained another 8.9% during the after-market hours following ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

Mindray, one of the world's leading developers and providers of advanced medical imaging devices and solutions, launched ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

Researchers at Northwestern Medicine Canning Thoracic Institute have uncovered a startling connection between COVID-19 infections and cancer regression, raising the possibility of using the virus's ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...